Back to top

Alliance Global Partners Sticks to Its Buy Rating for Tonix Pharma (TNXP)

In a report released today, James Molloy from Alliance Global Partners reiterated a Buy rating on Tonix Pharma, with a price target of $65.00. Acco...

Read full article here »

In-Depth Zacks Research for the Tickers Above

Normally $25 each - click below to receive one report FREE: